Boston Scientific Co. (NYSE:BSX) Given Consensus Recommendation of “Buy” by Brokerages
Boston Scientific Co. (NYSE:BSX – Get Free Report) has been given an average recommendation of “Buy” by the twenty-three ...
Neurostimulation Devices Market Valuation To Surpass US$ 22.64 Billion by 2033 | Astute Analytica
Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...
Boston Scientific (NYSE:BSX) Given New $115.00 Price Target at Stifel Nicolaus
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective hoisted by research analysts at Stifel Nicolaus from ...
Nasdaq8d
Boston Scientific announces results for fourth quarter and full year 2024
The GAAP financial measures most directly comparable to adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders and adjusted net income (loss ...
Yahoo Finance19d
Boston Scientific's (NYSE:BSX) five-year earnings growth trails the solid shareholder returns
For instance, the price of Boston Scientific Corporation (NYSE:BSX) stock is up an impressive 143% over the last five years. Also pleasing for shareholders was the 20% gain in the last three months.